Ticalicibart
Ticalicibart is a humanized IgG4κ monoclonal antibody inhibitor targeting PCSK9. Ticalicibart has anti-hyperlipidaemic activity. Ticalicibart can be used for cardiovascular disease like hypercholesterolaemia research[1][2].
Product Specifications
CAS Number
[3033317-31-3]
UNSPSC
12352100
Target
PCSK9
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
References & Citations
[1]Seidah NG, et al. PCSK9: a key modulator of cardiovascular health. Circ Res. 2014 Mar 14;114 (6) :1022-36. |[2]Internacionales D C. International Nonproprietary Names for Pharmaceutical Substances (INN) [J]. WHO Drug Information, 2025, 39 (2) .
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1349073-01 0.02 mg (E-Coli)
Recombinant Rickettsia bellii SCO2-like protein RBE_0699 (RBE_0699)
Ask
View Details 
MBS1349073-02 0.1 mg (E-Coli)
Recombinant Rickettsia bellii SCO2-like protein RBE_0699 (RBE_0699)
Ask
View Details 
MBS1349073-03 0.02 mg (Yeast)
Recombinant Rickettsia bellii SCO2-like protein RBE_0699 (RBE_0699)
Ask
View Details MBS1349073-04 0.1 mg (Yeast)
Recombinant Rickettsia bellii SCO2-like protein RBE_0699 (RBE_0699)
Ask
View Details MBS1349073-05 0.02 mg (Baculovirus)
Recombinant Rickettsia bellii SCO2-like protein RBE_0699 (RBE_0699)
Ask
View Details MBS1349073-06 0.02 mg (Mammalian-Cell)
Recombinant Rickettsia bellii SCO2-like protein RBE_0699 (RBE_0699)
Ask
View Details